Misoprostol administration for the treatment of post-partum uterine atony: clinical effectiveness, safety, and guidelines
CADTH
Record ID 32014000101
English
Authors' recommendations:
Eight relevant systematic reviews, two randomized controlled trials, and four evidence-based guidelines were identified regarding the prevention and treatment of post-partum hemorrhage following vaginal birth.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.cadth.ca/media/pdf/htis/aug-2013/RB0608%20Misoprostol%20Uterine%20Atony%20final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Female
- Postpartum Hemorrhage
- Uterine Diseases
- Pre-Eclampsia
- Oxytocin
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.